Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it again with all this good news?

| More on:
Cannabis grows at a commercial farm.

Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I never thought I would say this again, but Canopy Growth (TSX:WEED) has been on an absolute tear recently. Canopy Growth stock saw its share price surge last week, ending the week up 113% just since March 14!

The reason for the growth could mean that we see Canopy Growth stock double yet again in 2024. So, let’s look at what happened and what it would take to achieve even more.

Created with Highcharts 11.4.3Canopy Growth PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.ca

Government backing

To be clear, the government isn’t backing Canopy Growth stock. However, the president and vice president of the United States have been making some clear moves in support of marijuana legalization. First and foremost, this comes down to the rescheduling of cannabis as a Schedule I narcotic.

This scheduling puts it in the same category as something like cocaine, and VP Kamala Harris called this “ridiculous” two weeks ago. Harris called on the Drug Enforcement Administration (DEA) to speed up the rescheduling — to which the DEA stated it was in the process of taking a look.

This comes as the U.S. gets closer and closer to a federal election in November. Marijuana continues to be a hot topic for President Biden; he referenced it in his recent State of the Union address. And with 40 states currently legalizing the product, it shows that he could have an advantage with ongoing support of at least rescheduling the drug.

Germany folds in

While the news out of the U.S. is promising, it’s not exactly federal legalization. However, Canopy Growth stock had even more great news come its way. It was announced that as of April 1, that Germany would recognize marijuana as a non-narcotic. The news marks a “monumental shift in the legal treatment and cultural acceptance of cannabis,” Canopy Growth stock said in a statement.

Canopy Growth stock went on to state that this provides a unique opportunity for the company to expand — not just through the medical avenue but through its commercial presence in the country. This would be through its current Story & Bickel vaporizer brand as well as the current medical offerings.

This legalization is enormous given that Germany continues to hold the largest gross domestic product (GDP) in Europe. With this exposure, Canopy Growth stock could see massive revenue increases in the next year.

What’s next?

There has been a lot of great news in the cannabis industry. However, there hasn’t been much coming from Canopy Growth stock itself. The company sold off a lot of its production properties as well as non-essential businesses over the last few years. This was to reduce costs and pay off debt. And Canopy Growth stock still has a lot of debt on hand.

This adds to its continued miss of earnings estimates, including the latest quarter. However, what investors seem to be more focused on these days is the future. So, should Canopy Growth stock come up with a clear path to profitability from these recent announcements, this could sincerely generate more investor interest.

With all that being said, Canopy Growth stock has already doubled in the last two weeks. So, can the company do it again? Frankly, I believe so — especially with more news like this coming its way.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Canopy Growth Corporation. The Motley Fool has a disclosure policy.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »